基于肠道益生菌的纳米颗粒用于细胞毒性siRNA输送,用于抗癌免疫疗法

Manfang Zhu1, Xiaohua Chen2, Yueyang Zhang1

  • 1Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.

概括

这项研究引入了一种基于Lactobacillus reuteri的新平台,用于癌症免疫疗法. 双功能载体增强免疫反应,并提供siRNA以有效抑制瘤.